Shintaro Miyamoto

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis

Kosuke Hamai, Hiroshi Iwamoto, Nobuhisa Ishikawa et al. · Disease Markers · 2016 · 149 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +15

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer

Yu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi et al. · Respiratory Investigation · 2019 · 119 citations

Medicine, Immunology, Oncology +16

Characteristics of inspiratory and expiratory reactance in interstitial lung disease

Aya Sugiyama, Noboru Hattori, Yoshinori Haruta et al. · Respiratory Medicine · 2013 · 112 citations · Full text

Medicine, Internal Medicine, Physiology +10

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers

Kiyofumi Shimoji, Takeshi Masuda, Kakuhiro Yamaguchi et al. · JAMA Network Open · 2020 · 68 citations · Full text

Medicine, Immunology, Oncology +15

Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma

Hiromi Honda, Minoru Fujimoto, Shintaro Miyamoto et al. · PLoS ONE · 2016 · 64 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +13